dapi catalog Search Results


dapi (4’, 6-diamidino-2-phenylindole  (Solarbio Inc)
90
Solarbio Inc dapi (4’, 6-diamidino-2-phenylindole
a , Anterograde tracing rAAVs. b , c , The schematic of the anterograde tracing strategy. Diagram of virus injection site in the PrL and optical fiber implantation site in the dCA1. d , The schematic of the experimental timeline of rAAVs expression and METH-CPP test on 12th day (no opto) combining with light stimulation on 13th day (with opto). e , METH-CPP expression in mCherry (n=8 mice) vs. ChR2-mCherry expressing mice (n=9 mice). (two-way ANOVA, interaction, F (2,45) =4.958, P =0.0113; CPP (pre-, post-no, post-with opto), F (1,45) =3.955, P =0.0528; mCherry (n.c, ChR2), F (2,45) =14.95, P <0.0001, Bonferroni’s multiple comparisons test), n.c, negative control group. f , METH-CPP expression in mCherry (n=8 mice) vs. eNpHR3.0-mCherry expressing mice (n=7 mice). (two-way ANOVA, interaction, F (2,39) =3.210, P =0.0512; CPP (pre-, post-no, post-with opto), F (1,39) =7.004, P= 0.0117; mCherry (n.c, eNpHR3.0), F (2,39) =24.71, P= 0.0001, Bonferroni’s multiple comparisons test), n.c, negative control group. g , h , Expression of mCherry and <t>DAPI</t> in the PrL (g) and dCA1 (h) (n = 3 mice), <t>DAPI,</t> <t>4′,6-diamidino-2-phenylindole,</t> Scale bar, 100 μm, 20 μm. i , The schematic of the experimental timeline of rAAVs expression and METH-CPP test on 12th day (with opto). j , METH-CPP expression in mCherry (n=7 mice) vs. ChR2-mCherry expressing mice (n=8 mice). (two-way ANOVA, interaction, F (1,26) =9.920, P =0.0041; CPP (pre-, post-with opto), F (1,26) =17.21, P =0.0003; mCherry (n.c, ChR2), F (1,26) =14.61, P =0.0007, Bonferroni’s multiple comparisons test), n.c, negative control group. k , METH-CPP expression in mCherry (n=7 mice) vs. eNpHR3.0-mCherry expressing mice (n=6 mice). (two-way ANOVA, interaction, F (1,22) =3.902, P =0.0609; CPP (pre-, post-with opto), F (1,22) =5.981, P =0.0229; mCherry (n.c, eNpHR3.0), F (1,22) =66.58, P < 0.0001, Bonferroni’s multiple comparisons test), n.c, negative control group. l , m , The expression of mCherry and DAPI in the PrL ( l ) and dCA1 ( m ) (n = 3 mice). Scale bar, 100 μm, 20 μm. Data in e , f , j , k are presented as means±s.e.m. Two-sided statistical tests were used. *p <0.05, **p <0.01, ***p <0.001; ns, not significant.
Dapi (4’, 6 Diamidino 2 Phenylindole, supplied by Solarbio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dapi (4’, 6-diamidino-2-phenylindole/product/Solarbio Inc
Average 90 stars, based on 1 article reviews
dapi (4’, 6-diamidino-2-phenylindole - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
dapi (diluted 1:10,000; catalog no. c1002  (BIOCYTOGEN ltd)
90
BIOCYTOGEN ltd dapi (diluted 1:10,000; catalog no. c1002
a , Anterograde tracing rAAVs. b , c , The schematic of the anterograde tracing strategy. Diagram of virus injection site in the PrL and optical fiber implantation site in the dCA1. d , The schematic of the experimental timeline of rAAVs expression and METH-CPP test on 12th day (no opto) combining with light stimulation on 13th day (with opto). e , METH-CPP expression in mCherry (n=8 mice) vs. ChR2-mCherry expressing mice (n=9 mice). (two-way ANOVA, interaction, F (2,45) =4.958, P =0.0113; CPP (pre-, post-no, post-with opto), F (1,45) =3.955, P =0.0528; mCherry (n.c, ChR2), F (2,45) =14.95, P <0.0001, Bonferroni’s multiple comparisons test), n.c, negative control group. f , METH-CPP expression in mCherry (n=8 mice) vs. eNpHR3.0-mCherry expressing mice (n=7 mice). (two-way ANOVA, interaction, F (2,39) =3.210, P =0.0512; CPP (pre-, post-no, post-with opto), F (1,39) =7.004, P= 0.0117; mCherry (n.c, eNpHR3.0), F (2,39) =24.71, P= 0.0001, Bonferroni’s multiple comparisons test), n.c, negative control group. g , h , Expression of mCherry and <t>DAPI</t> in the PrL (g) and dCA1 (h) (n = 3 mice), <t>DAPI,</t> <t>4′,6-diamidino-2-phenylindole,</t> Scale bar, 100 μm, 20 μm. i , The schematic of the experimental timeline of rAAVs expression and METH-CPP test on 12th day (with opto). j , METH-CPP expression in mCherry (n=7 mice) vs. ChR2-mCherry expressing mice (n=8 mice). (two-way ANOVA, interaction, F (1,26) =9.920, P =0.0041; CPP (pre-, post-with opto), F (1,26) =17.21, P =0.0003; mCherry (n.c, ChR2), F (1,26) =14.61, P =0.0007, Bonferroni’s multiple comparisons test), n.c, negative control group. k , METH-CPP expression in mCherry (n=7 mice) vs. eNpHR3.0-mCherry expressing mice (n=6 mice). (two-way ANOVA, interaction, F (1,22) =3.902, P =0.0609; CPP (pre-, post-with opto), F (1,22) =5.981, P =0.0229; mCherry (n.c, eNpHR3.0), F (1,22) =66.58, P < 0.0001, Bonferroni’s multiple comparisons test), n.c, negative control group. l , m , The expression of mCherry and DAPI in the PrL ( l ) and dCA1 ( m ) (n = 3 mice). Scale bar, 100 μm, 20 μm. Data in e , f , j , k are presented as means±s.e.m. Two-sided statistical tests were used. *p <0.05, **p <0.01, ***p <0.001; ns, not significant.
Dapi (Diluted 1:10,000; Catalog No. C1002, supplied by BIOCYTOGEN ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dapi (diluted 1:10,000; catalog no. c1002/product/BIOCYTOGEN ltd
Average 90 stars, based on 1 article reviews
dapi (diluted 1:10,000; catalog no. c1002 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


a , Anterograde tracing rAAVs. b , c , The schematic of the anterograde tracing strategy. Diagram of virus injection site in the PrL and optical fiber implantation site in the dCA1. d , The schematic of the experimental timeline of rAAVs expression and METH-CPP test on 12th day (no opto) combining with light stimulation on 13th day (with opto). e , METH-CPP expression in mCherry (n=8 mice) vs. ChR2-mCherry expressing mice (n=9 mice). (two-way ANOVA, interaction, F (2,45) =4.958, P =0.0113; CPP (pre-, post-no, post-with opto), F (1,45) =3.955, P =0.0528; mCherry (n.c, ChR2), F (2,45) =14.95, P <0.0001, Bonferroni’s multiple comparisons test), n.c, negative control group. f , METH-CPP expression in mCherry (n=8 mice) vs. eNpHR3.0-mCherry expressing mice (n=7 mice). (two-way ANOVA, interaction, F (2,39) =3.210, P =0.0512; CPP (pre-, post-no, post-with opto), F (1,39) =7.004, P= 0.0117; mCherry (n.c, eNpHR3.0), F (2,39) =24.71, P= 0.0001, Bonferroni’s multiple comparisons test), n.c, negative control group. g , h , Expression of mCherry and DAPI in the PrL (g) and dCA1 (h) (n = 3 mice), DAPI, 4′,6-diamidino-2-phenylindole, Scale bar, 100 μm, 20 μm. i , The schematic of the experimental timeline of rAAVs expression and METH-CPP test on 12th day (with opto). j , METH-CPP expression in mCherry (n=7 mice) vs. ChR2-mCherry expressing mice (n=8 mice). (two-way ANOVA, interaction, F (1,26) =9.920, P =0.0041; CPP (pre-, post-with opto), F (1,26) =17.21, P =0.0003; mCherry (n.c, ChR2), F (1,26) =14.61, P =0.0007, Bonferroni’s multiple comparisons test), n.c, negative control group. k , METH-CPP expression in mCherry (n=7 mice) vs. eNpHR3.0-mCherry expressing mice (n=6 mice). (two-way ANOVA, interaction, F (1,22) =3.902, P =0.0609; CPP (pre-, post-with opto), F (1,22) =5.981, P =0.0229; mCherry (n.c, eNpHR3.0), F (1,22) =66.58, P < 0.0001, Bonferroni’s multiple comparisons test), n.c, negative control group. l , m , The expression of mCherry and DAPI in the PrL ( l ) and dCA1 ( m ) (n = 3 mice). Scale bar, 100 μm, 20 μm. Data in e , f , j , k are presented as means±s.e.m. Two-sided statistical tests were used. *p <0.05, **p <0.01, ***p <0.001; ns, not significant.

Journal: bioRxiv

Article Title: The Prefrontal Cortex to the Hippocampus Glutamatergic Pathway Regulates Reward Effects of Methamphetamine

doi: 10.1101/2024.05.20.595065

Figure Lengend Snippet: a , Anterograde tracing rAAVs. b , c , The schematic of the anterograde tracing strategy. Diagram of virus injection site in the PrL and optical fiber implantation site in the dCA1. d , The schematic of the experimental timeline of rAAVs expression and METH-CPP test on 12th day (no opto) combining with light stimulation on 13th day (with opto). e , METH-CPP expression in mCherry (n=8 mice) vs. ChR2-mCherry expressing mice (n=9 mice). (two-way ANOVA, interaction, F (2,45) =4.958, P =0.0113; CPP (pre-, post-no, post-with opto), F (1,45) =3.955, P =0.0528; mCherry (n.c, ChR2), F (2,45) =14.95, P <0.0001, Bonferroni’s multiple comparisons test), n.c, negative control group. f , METH-CPP expression in mCherry (n=8 mice) vs. eNpHR3.0-mCherry expressing mice (n=7 mice). (two-way ANOVA, interaction, F (2,39) =3.210, P =0.0512; CPP (pre-, post-no, post-with opto), F (1,39) =7.004, P= 0.0117; mCherry (n.c, eNpHR3.0), F (2,39) =24.71, P= 0.0001, Bonferroni’s multiple comparisons test), n.c, negative control group. g , h , Expression of mCherry and DAPI in the PrL (g) and dCA1 (h) (n = 3 mice), DAPI, 4′,6-diamidino-2-phenylindole, Scale bar, 100 μm, 20 μm. i , The schematic of the experimental timeline of rAAVs expression and METH-CPP test on 12th day (with opto). j , METH-CPP expression in mCherry (n=7 mice) vs. ChR2-mCherry expressing mice (n=8 mice). (two-way ANOVA, interaction, F (1,26) =9.920, P =0.0041; CPP (pre-, post-with opto), F (1,26) =17.21, P =0.0003; mCherry (n.c, ChR2), F (1,26) =14.61, P =0.0007, Bonferroni’s multiple comparisons test), n.c, negative control group. k , METH-CPP expression in mCherry (n=7 mice) vs. eNpHR3.0-mCherry expressing mice (n=6 mice). (two-way ANOVA, interaction, F (1,22) =3.902, P =0.0609; CPP (pre-, post-with opto), F (1,22) =5.981, P =0.0229; mCherry (n.c, eNpHR3.0), F (1,22) =66.58, P < 0.0001, Bonferroni’s multiple comparisons test), n.c, negative control group. l , m , The expression of mCherry and DAPI in the PrL ( l ) and dCA1 ( m ) (n = 3 mice). Scale bar, 100 μm, 20 μm. Data in e , f , j , k are presented as means±s.e.m. Two-sided statistical tests were used. *p <0.05, **p <0.01, ***p <0.001; ns, not significant.

Article Snippet: After rinsing in PBS, the slices were incubated with fluorescence-conjugated secondary antibody at room temperature for 2 h. Finally, slices were coverslipped on anti-fluorescence attenuation tablets including DAPI (4’, 6-diamidino-2-phenylindole) (Solarbio).

Techniques: Anterograde Tracing, Virus, Injection, Expressing, Negative Control